Genomic Health to Present Multiple Abstracts at ASCO on Oncotype DX

The company will present two new studies looking at triple-negative breast cancer and male breast cancer at ASCO's annual meeting later this month. Also, a study with Pfizer in renal cancer will start later this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.